Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
New soft robotic device achieves 96% success rate in emergency intubation with minimal training
, /in E-News, Emergency Medicine, Research /by panglobalA novel soft robotic device has enabled emergency medical personnel to achieve intubation success rates as high as 96% with only five minutes of training, according to new research published in Science Translational Medicine. The vine-like device could dramatically expand access to life-saving airway management in emergency situations and resource-limited settings.
Philips unveils AI-enhanced cardiovascular ultrasound platform
, /in Product News /by panglobalPhilips has unveiled Transcend Plus, the next generation of its EPIQ CVx and Affiniti CVx cardiovascular ultrasound systems, delivering significant advancements in artificial intelligence integration and image quality enhancement.
Scientists develop portable bone printer to create custom implants during surgery
bone printer, Sungkyunkwan University, /in E-News, Orthopaedics /by panglobalScientists have engineered a portable 3D printing device that produces bone grafts directly onto fractures during surgery. The technology enables real-time fabrication of customised implants without pre-operative preparation, whilst incorporating antibiotics to prevent infection and promoting natural bone regeneration at the grafting site.
Phraxis completes first commercial EndoForce connector case
, /in Product News /by panglobalPhraxis, Inc. has successfully completed the world’s first commercial case using its FDA-approved EndoForceAnastomotic Connector, establishing a pivotal milestone in dialysis vascular access innovation. The groundbreaking procedure, performed at Spartanburg Regional Medical Center in South Carolina, signals the beginning of U.S. commercialisation for this novel endovascular device designed to standardise arteriovenous graft creation.
Abbott expands Navitor TAVI system indication in Europe
Abbot, /in Product News /by panglobalAbbott has received CE mark approval in Europe for an expanded indication of its Navitor™ transcatheter aortic valve implantation (TAVI) system, significantly broadening treatment options for patients with symptomatic, severe aortic stenosis. The minimally invasive device is now approved for patients at low or intermediate surgical risk, complementing its existing approval for high and extreme-risk […]
Fitness emerges as key shield against cardiac arrhythmias in healthy adults
aerobic fitness, cardiac arrhythmias, /in Cardiology, E-News /by panglobalComprehensive cardiac monitoring reveals that low aerobic fitness and advancing age independently drive irregular heartbeat patterns previously dismissed as benign, with implications for preventive screening strategies starting at age 50.
Scientists create first complete brain-wide activity map during decision-making
decision-making, International Brain Laboratory, /in E-News, Editors' Picks, Featured Articles, Neurology /by panglobalResearchers from the International Brain Laboratory have unveiled the first brain-wide activity map showing how decision-making unfolds across the entire brain in mice at single-cell resolution. The comprehensive study recorded from over 621,000 neurons across 279 brain areas, revealing that decision-making is distributed across many regions in a highly coordinated way.
Beta-blocker standard of care challenged by landmark heart attack trial
beta blockers, /in Cardiology, E-News, pharmacology /by panglobalA major international clinical trial has overturned four decades of standard cardiac care, finding that beta-blockers provide no benefit for most heart attack survivors with preserved heart function. The REBOOT study, involving over 8,500 patients, could reshape treatment guidelines worldwide.
SNMMI launches AI-powered trial finder for radiopharmaceuticals
Global Radiopharmaceutical Trial Finder, /in E-News /by panglobalThe Society of Nuclear Medicine and Molecular Imaging has unveiled a comprehensive digital platform designed to streamline patient access to radiopharmaceutical clinical trials. The Global Radiopharmaceutical Trial Finder utilises artificial intelligence to match patients, physicians, and researchers with relevant studies across multiple international registries, addressing critical gaps in clinical trial participation rates.
New non-invasive blood flow test outperforms standard Alzheimer’s diagnostic markers
Alzheimer’s, /in dementia, E-News, Neurology /by panglobalA groundbreaking diagnostic test measuring brain blood flow dynamics has demonstrated superior accuracy in detecting Alzheimer’s disease compared to traditional markers, achieving a 96% diagnostic performance rate. The non-invasive cerebrovascular test offers hope for earlier, more accessible dementia screening whilst challenging conventional amyloid-focused diagnostic approaches.